Baxter International Shares Rise 19% on Strong Q2 Earnings and Raised Guidance
Baxter International (NYSE: BAX) saw its stock surge by nearly 19% during the week following a strong quarterly earnings report. The medical device company reported second-quarter sales of $2.96 billion, up 5% year-over-year with both U.S. and international revenue showing growth. GAAP net income increased to $135 million from $122 million in the prior year period. Baxter also raised its full-year guidance for both sales and adjusted earnings per share (EPS), citing strong performance across product lines. Medical products and therapies saw a 7% increase, while healthcare systems and technologies rose by 4%. Analysts had expected lower revenue and EPS figures than what was reported. The company's improved outlook reflects its solid position in the aging population-driven medical care market. Baxter is seen as well-positioned for continued growth.
Tickers: $BAX
Topics: financial_performance medical_devices